Incretin manipulation in diabetes management.

about

Medical Management of Diabesity: Do We Have Realistic Targets?Diabetes-related dysfunction of the small intestine and the colon: focus on motility.Teneligliptin: a review in type 2 diabetes.Non-alcoholic Fatty Liver Disease: A Clinical Update.

P2860

Q30238940-298BF652-D90C-4E06-91B9-3C3F85E2CE18 Q38587718-8891A243-9E4D-4732-A777-774A379805BE Q38609598-0A899DDB-B9F3-4BB6-82D6-394E99DF1C24 Q47100244-65D04C23-A500-4037-9C89-74B6651A9934

P2860

Incretin manipulation in diabetes management.

Item

http://www.wikidata.org/entity/Q41906284

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Incretin manipulation in diabetes management.

@en

type

Item

label

Incretin manipulation in diabetes management.

@en

prefLabel

Incretin manipulation in diabetes management.

@en

P1476

Incretin manipulation in diabetes management.

@en

P2093

A V Raveendran

http://www.w3.org/2001/XMLSchema#string

Joseph M Pappachan

http://www.w3.org/2001/XMLSchema#string

Rajagopalan Sriraman

http://www.w3.org/2001/XMLSchema#string

P2860

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors

Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetes

Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination

Standards of medical care in diabetes--2014

The Physiology of Glucagon-like Peptide 1

Biology of incretins: GLP-1 and GIP

Teneligliptin as an initial therapy for newly diagnosed, drug naive subjects with type 2 diabetes

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus.

Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus.

P304

774-781

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4239/WJD.V6.I6.774

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279732624

http://www.w3.org/2001/XMLSchema#string

P698

26131320

http://www.w3.org/2001/XMLSchema#string

P932

4478574

http://www.w3.org/2001/XMLSchema#string

Incretin manipulation in diabetes management.

about

P2860

P2860

Incretin manipulation in diabetes management.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932